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Abstract
Resumo
In cases where typical aspects are shown, the diagnosis of most frequent hepatic lesions can be made with some safety by means of
several imaging methods; on the other hand, uncommon lesions generally represent a diagnostic challenge for the radiologist. In the
present second part of the study, the authors describe four rare hepatic lesions, as follows: primary hepatic lymphoma, myofibroblastic
tumor, primary hepatic neuroendocrine tumor and desmoplastic small round cell tumor, approaching their main characteristics and imaging
findings with emphasis on computed tomography and magnetic resonance imaging.
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O diagnóstico das lesões hepáticas mais frequentes pode ser feito com alguma segurança quando exibem aspectos típicos, utilizando-
se os diversos métodos de imagem; ao contrário, as lesões incomuns são geralmente um desafio diagnóstico para o radiologista. Nesta
segunda parte do estudo serão descritas quatro raras lesões hepáticas: o linfoma hepático primário, o tumor miofibroblástico, o carcinoma
neuroendócrino primário do fígado e o tumor desmoplásico de pequenas células, abordando as suas principais características e achados
de imagem, com foco na tomografia computadorizada e ressonância magnética.
Unitermos: Neoplasias; Fígado; Atípicos; Tomografia computadorizada; Ressonância magnética.
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tory pseudotumors (myofibroblastic tumors) and some sar-
comas(3).
Few studies are available in the literature providing a
comparative and comprehensive analysis of imaging findings
of uncommon liver tumors.
The objective of the present study is, by means of a pic-
torial essay, to describe the main imaging findings of sev-
eral uncommon benign and malignant liver tumors observed
at computed tomography (CT) and magnetic resonance im-
aging (MRI). The following entities will be approached in
this second part of the study: primary hepatic lymphoma;
myofibroblastic tumor; primary hepatic neuroendocrine tu-
mor; and desmoplastic small round cell.
PRIMARY HEPATIC LYMPHOMA
Primary hepatic lymphoma (PHL) is an extremely rare
neoplasm, corresponding to less than 1% of extranodal lym-
phomas. It is defined as a primary liver tumor as there is no
involvement of the spleen, lymph nodes or other distant sites
at the moment of the diagnosis. There is a predilection for
males (3 men:1 woman), usually at the fifth decade of life(4).
At the moment of the diagnosis, the symptoms are nonspe-
cific and the patients may present with abdominal discom-
fort and fever. There is a strong association with immuno-
suppression, hepatitis B and C, human immunodefficiency
and Epstein-Barr viruses(5,6).
In about 60% of cases such tumors present as solitary,
well defined masses (> 4 cm) which demonstrate peripheral
lamellar enhancement after intravenous contrast media in-
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INTRODUCTION
A wide variety of tumors affect the liver, and 90% of focal
liver lesions are benign. Amongst benign liver lesions, heman-
giomas and focal nodular hyperplasias (FNH) are the most
common non-cystic lesions(1). Metastases are the most fre-
quently found malignant neoplasms, hepatocellular carcino-
mas (HCC) being responsible for 80–85% of primary malig-
nant tumors, followed by intrahepatic cholangiocarcinomas(2).
The diagnosis of typical liver lesions can be safely made
with different imaging methods; by contrast, uncommon
lesions generally represent a diagnostic challenge for radi-
ologists.
Among tumors considered uncommon, one highlights
epithelial tumors, such as cystadenomas and biliary cystad-
enocarcinomas, non epithelial tumors including angiomyo-
lipomas, epithelioid hemangioendotheliomas and angiosar-
comas, besides other tumors such as lymphomas, inflamma-
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jection, and may rarely calcify, simulating hypovascular
metastasis from the gastrointestinal tract, presenting with a
target sign (Figures 1 and 2). Multinodular and infiltrative
presentations are less frequently observed and are generally
related to liver involvement by systemic lymphoma(5).
Some findings suggest the diagnosis of PHL:
• Absence of involvement of other extranodal sites.
• Solitary mass presenting with peripheral lamellar en-
hancement.
• Target sign without a known primary tumor.
• Immunosuppressed patient.
INFLAMMATORY TUMOR (MYOFIBROBLASTIC
TUMOR)
It is a rare liver lesion characterized by chronic inflam-
mation, with fibroblasts proliferation which may compro-
mise different organs but is most frequently is found in lungs
and liver(7). It is also known as xanthogranuloma, histiocy-
toma, pseudolymphoma or fibroxanthoma. Currently it is
known as inflammatory myofibroblastic tumor (IMT)(8).
This tumor is most frequently found in male young adults
and in general presents a benign evolution. Its etiology still
remains unknown and may be related to inflammatory-in-
fectious processes (hepatitis and repetition cholangitis) and
self-immune diseases(8).
Symptoms are nonspecific and include fever, abdomi-
nal pain, weight loss and jaundice. Generally, this tumor is
a solitary mass and in 20% of cases develops as a multiple
and synchronous mass, most frequently located in the right
liver lobe, measuring 1–20 cm in its greater diameter(8).
Laboratory analysis frequently demonstrates leukocytosis,
eosinophilia and increased hemosedimentation velocity
Figure 2. MRI of a patient with primary hepatic lymphoma. Heterogeneous mass in the right liver lobe, with target sign and hyposignal on T1-weighted (A) and moderate
to hypersignal on T2-weighted sequences (B).
Figure 1. Primary hepatic lymphoma. A: Ultrasonography demonstrating heterogeneous liver mass located in the confluence between the right and left lobes with target
sign. B: Correlation with CT highlights peripheral, lamellar enhancement after intravenous contrast agent injection.
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(HSV). Cases of patients presenting increased levels of tu-
mor markers such as CA 19-9 have already been reported(7,9).
CT usually demonstrates a hypodense mass with periph-
eral, heterogeneous enhancement, with a poorly vascularized
central area. Compressive effects of the mass may occur, de-
termining dilatation of the biliary tract and portal hyperten-
sion (Figure 3). MRI is one of the best methods capable of
better characterizing an inflammatory tumor. A focal, mass-
type lesion is the most common appearance and presents with
low signal intensity on T1-weighted images and slightly in-
creased signal on T2-weighted images, sometimes with in-
termingled foci of marked hypersignal. After paramagnetic
contrast media injection, intense and heterogeneous enhance-
ment is observed, particularly in the periphery of the lesion(8).
Generally, histopathological correlation is required to
establish a definitive diagnosis of inflammatory tumor that
includes intrahepatic cholangiocarcinoma, liver abscess and
HCC amongst its differential diagnoses(7).
Main findings suggestive of the diagnosis of IMT include:
• Laboratory tests: leukocytosis and increased HSV.
• Association with autoimmune diseases.
• Solitary mass in the right liver lobe, with heterogeneous
peripheral enhancement.
• Resolution of the condition after either antibiotic therapy
or corticotherapy.
PRIMARY HEPATIC NEUROENDOCRINE TUMOR
Primary hepatic neuroendocrine tumor (PHNT) repre-
sents less than 0.3% of all neuroendocrine tumors. It is most
commonly found in women in seventh decade of life. Symp-
toms are nonspecific and include abdominal pain, palpable
abdominal mass, fatigue and weight loss. More than 10% of
cases are asymptomatic and only a small percentage of pa-
tients present with carcinoid syndrome (facial flush, abdomi-
nal pain and diarrhea)(10).
The diagnosis of primary hepatic carcinoid tumor is
based on histological and immunohistochemical analysis and
principally on exclusion of metastatic disease. Scintigraphy
with somatostatin analog drug (OctreoScan) is a useful tech-
nique for the diagnosis of functional neuroendocrine tumors,
Figure 3. Inflammatory pseudotumor. A 66-year-old man with pain in the right hypochondrium associated with fever and leukocytosis. Non-contrast enhanced CT (A)
and after intravenous contrast injection (B,C) demonstrates the presence of a hypodense and hypovascularized lesion in the segments II and IV, with permeative
appearance, simulating infiltrating lesion. Follow-up CT three-month after antibiotic therapy demonstrates complete lesion regression (D).
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with up to 90% sensitivity. On the other hand, PET/CT is
an imaging modality reserved for the diagnosis of non func-
tional tumors. Surgical resection is the treatment of choice
and transcatheter arterial chemoembolization is an excellent
palliative option in cases of recurrent lesions(11).
CT imaging findings include either single or multiple
solid, hypervascularized lesions intermingled with areas of
necrosis and calcifications (Figure 4). At MRI, the lesions
present low signal intensity on T1-weighted and high signal
intensity on T2-weighted sequences(10) (Figures 5 and 6).
The differential diagnoses is broad, however, one should
consider the possibility of hypervascular metastasis, HCC,
cholangiocarcinoma with neuroendocrine differentiation and
epithelioid variant of gastrointestinal stromal tumor(10).
Some findings may be useful to consider PHNT as a
pertinent hypothesis among differential diagnoses:
• Women between their sixth and seventh decades of life.
• Presence of heterogeneous, hypervascular mass with no
history of hepatopathy.
• Eventual association with carcinoid syndrome.
DESMOPLASTIC SMALL ROUND CELL TUMOR
Desmoplastic small round cell tumor (DSCT) is a rare
mesenchymal and highly aggressive tumor, with about 200
cases described in the literature. Its incidence is highest in
adolescent and young adults (mean age, 22 years), preferen-
tially in male individuals (4 men:1 woman)(12). The reported
location is almost exclusively intra-abdominal, without a
clearly identified visceral origin, affecting the omentum and
peritoneal implants involving the diaphragm, splenic hilum,
intestinal mesenterium and pelvic peritoneum(13).
Organs involvement is inconstant and secondary, and
liver and lungs represent the main common sites for meta-
static disease, besides the peritoneum(11).
Clinical manifestations of intra-abdominal DSCT are
usually nonspecific and most frequently involve vague pel-
vic or abdominal symptoms and palpable masses(13).
Imaging findings demonstrate intraperitoneal tumor
mass without identifying the lesion site (organ) in associa-
tion with multiple peritoneal implants and ascites. At CT
Figure 4. Primary hepatic neuroendocrine carcinoma. Computed tomography, non-contrast enhanced image (A) and after intravenous contrast media injection (B,C,D)
demonstrate the presence of a heterogeneous, quite vascularized mass with some foci of calcification and intermingled cystic areas, occupying the left liver lobe.
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and MRI, such tumors present as masses with soft tissue den-
sity, with central foci suggesting necrosis and hemorrhage,
with moderate enhancement following intravenous contrast
injection, and calcifications in 22% of cases(13)(Figure 7).
DSCT may be considered in the presence of intraperi-
toneal masses with visceral extension, with no defined pri-
mary site occurring in young patients.
Figure 5. Primary hepatic neuroendocrine carcinoma (same patient on Figure 4). MRI, T1--weighted (A), T2-weighted (B) and contrast-enhanced (C) sequences
demonstrate heterogeneous mass with hyposignal on T1-weighted and hypersignal on T2-weighted images intermingled with multiple cystic areas (some of them with
fluid-fluid level). The lesion presented restriction to water diffusion at the diffusion sequence (D).
Figure 6. Primary hepatic neuroendocrine carcinoma (same patient on Figures 4 and 5). MRI, coronal T2-weighted image (A) demonstrates heterogeneous mass
occupying almost the whole left liver lobe, with hypersignal intermingled with multiple cystic areas, with excellent correspondence with the macroscopic aspect observed
on the surgical specimen (B).
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CONCLUSION
Despite their rarity, the tumors described in this second
part of the study should be recognized and considered by
radiologists as included in the differential diagnoses of liver
lesions, assisting not only in the therapeutic planning and
strategy, but also as a support in the definition of the anatomo-
pathological diagnosis.
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Figure 7. Desmoplastic small
round cell tumor. CT, portal phase
(A,B) demonstrates hypodense,
hypovascularized, expansile mass
infiltrating the hepatic hilum in as-
sociation with subtle segmental
dilatation of left intrahepatic biliary
tract. Also, an intraparenchymal
component is observed. T1- and
T2-weighted MRI images with fat
suppression (D) demonstrates
hyposignal from the lesion on T1-
weighted and hypersignal on T2-
weighted sequences extending to-
ward the hepatic hilum.
